Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-alfatide II and differentiation with tumors

Theranostics

Volumn 4, Issue 5, 2014, Pages 546-555

  Wu, Chenxi ^a,b   Yue, Xuyi ^b   Lang, Lixin ^b   Kiesewetter, Dale O ^b   Li, Fang ^a   Zhu, Zhaohui ^a   Niu, Gang ^b   Chen, Xiaoyuan ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Inflammation; Positron emission tomography; TSPO; Tumor

Indexed keywords

18F ALFATIDE II; 18F DPA 714; ARGININE; ASPARAGINE; CLODRONIC ACID; GLYCINE; TRACER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; COLON CANCER; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; IMMUNOFLUORESCENCE; ISOTOPE LABELING; LONGITUDINAL STUDY; LUNG CARCINOMA; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MYOSITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; TUMOR DIFFERENTIATION; XENOGRAFT;

18F-ALFATIDE II; 18F-DPA-714; INFLAMMATION; POSITRON EMISSION TOMOGRAPHY; TSPO; TUMOR;

ANIMALS; CELL LINE; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MACROPHAGES; MICE; MUSCLE NEOPLASMS; MYOSITIS; PEPTIDES, CYCLIC; POSITRON-EMISSION TOMOGRAPHY; PYRAZOLES; PYRIMIDINES;

EID: 84902504921     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.8159     Document Type: Article

References (40)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444: 860-7. doi:10.1038/nature05485.
2. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease--a double-edged sword. Neuron. 2002; 35: 419-32.
3. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006; 83: 456S-60S.
4. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7. doi:10.1038/nature01322.
5. Kostakoglu L, Agress H, Jr., Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics : a review publication of the Radiological Society of North America, Inc. 2003; 23: 315-40; quiz 533. doi:10.1148/rg.232025705.
6. Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012; 54: 1333-41. doi:10.1093/cid/cis193.
7. van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004; 45: 695-700.
8. van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, et al. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis Rheum. 2008; 58: 3350-5. doi:10.1002/art.23955.
9. Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum. 2012; 64: 62-6. doi:10.1002/art.30655.
10. Boutin H, Prenant C, Maroy R, Galea J, Greenhalgh AD, Smigova A, et al. [18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats. PLoS One. 2013; 8: e56441. doi:10.1371/journal.pone.0056441.
11. Harhausen D, Sudmann V, Khojasteh U, Muller J, Zille M, Graham K, et al. Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke. PLoS One. 2013; 8: e69529. doi:10.1371/journal.pone.0069529.
12. Yu I, Inaji M, Maeda J, Okauchi T, Nariai T, Ohno K, et al. Glial cell-mediated deterioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. J Neurotrauma. 2010; 27: 1463-75. doi:10.1089/neu.2009.1196.
13. Maeda J, Zhang MR, Okauchi T, Ji B, Ono M, Hattori S, et al. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. J Neurosci. 2011; 31: 4720-30. doi:10.1523/JNEUROSCI.3076-10.2011.
14. Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012; 33: 1902-10. doi:10.1093/eurheartj/ehr367.
15. Lamare F, Hinz R, Gaemperli O, Pugliese F, Mason JC, Spinks T, et al. Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med. 2011; 52: 33-9. doi:10.2967/jnumed.110.079038.
16. Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008; 35: 2304-19. doi:10.1007/s00259-008-0908-9.
17. Doorduin J, Klein HC, Dierckx RA, James M, Kassiou M, de Vries EF. [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imaging Biol. 2009; 11: 386-98. doi:10.1007/s11307-009-0211-6.
18. Chauveau F, Van Camp N, Dolle F, Kuhnast B, Hinnen F, Damont A, et al. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009; 50: 468-76. doi:10.2967/jnumed.108.058669.
19. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000; 2: 189-202. doi:10.1186/ar86.
20. Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005; 46: 4295-301. doi:10.1167/iovs.04-1057.
21. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 2002; 4: 449-60.
22. Beer AJ, Kessler H, Wester HJ, Schwaiger M. PET Imaging of Integrin alphaVbeta3 Expression. Theranostics. 2011; 1: 48-57.
23. Lee J, Lee TS, Ryu J, Hong S, Kang M, Im K, et al. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. J Nucl Med. 2013; 54: 96-103. doi:10.2967/jnumed.112.108043.
24. Cao Q, Cai W, Li ZB, Chen K, He L, Li HC, et al. PET imaging of acute and chronic inflammation in living mice. Eur J Nucl Med Mol Imaging. 2007; 34: 1832-42. doi:10.1007/s00259-007-0451-0.
25. Laitinen I, Saraste A, Weidl E, Poethko T, Weber AW, Nekolla SG, et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging. 2009; 2: 331-8. doi:10.1161/CIRCIMAGING.108.846865.
26. Guo J, Lang L, Hu S, Guo N, Zhu L, Sun Z, et al. Comparison of Three Dimeric F-AlF-NOTA-RGD Tracers. Mol Imaging Biol. 2013. doi:10.1007/s11307-013-0668-1.
27. Hamazawa Y, Koyama K, Okamura T, Wada Y, Wakasa T, Okuma T, et al. Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model. Ann Nucl Med. 2007; 21: 47-55.
28. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997; 2: d12-26.
29. Koneru R, Kobiler D, Lehrer S, Li J, van Rooijen N, Banerjee D, et al. Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injury. Neurosci Lett. 2011; 501: 148-51. doi:10.1016/j.neulet.2011.06.062.
30. Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, Tidball JG. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet. 2011; 20: 790-805. doi:10.1093/hmg/ddq523.
31. Tidball JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol. 2007; 578: 327-36. doi:10.1113/jphysiol.2006.118265.
32. Li J, Hsu HC, Yang P, Wu Q, Li H, Edgington LE, et al. Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model. Arthritis Rheum. 2012; 64: 1098-109. doi:10.1002/art.33423.
33. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol. 2003; 170: 1274-82.
34. Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology. 2002; 123: 256-70.
35. Wu C, Li F, Niu G, Chen X. PET imaging of inflammation biomarkers. Theranostics. 2013; 3: 448-66. doi:10.7150/thno.6592.
36. Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther. 2009; 17: 162-8. doi:10.1038/mt.2008.220.
37. Black KL, Ikezaki K, Santori E, Becker DP, Vinters HV. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer. 1990; 65: 93-7.
38. Zheng J, Boisgard R, Siquier-Pernet K, Decaudin D, Dolle F, Tavitian B. Differential expression of the 18 kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer. Mol Pharm. 2011; 8: 823-32. doi:10.1021/mp100433c.
39. Schmieder A, Michel J, Schonhaar K, Goerdt S, Schledzewski K. Differentiation and gene expression profile of tumor-associated macrophages. Seminars in cancer biology. 2012; 22: 289-97. doi:10.1016/j.semcancer.2012.02.002.
40. Quatromoni JG, Eruslanov E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. American journal of translational research. 2012; 4: 376-89.